Upstream & Downstream Processing
Bioprocessing blighted by ‘deteriorating funding,’ China, and post-COVID, say Danaher and Thermo
Upstream & Downstream ProcessingBioprocessing blighted by ‘deteriorating funding,’ China, and post-COVID, say Danaher and ThermoBioprocessing blighted by ‘deteriorating funding,’ China, and post-COVID, say Danaher and Thermo
A dry up of biotech funding is among the macroeconomic issues affecting growth in the bioprocessing space, say Thermo Fisher and Danaher.